Omnicell, Inc. (OMCL)

Market Cap	1.54B
Revenue (ttm)	1.19B
Net Income (ttm)	-34.40M
Shares Out	45.47M
EPS (ttm)	-0.74
PE Ratio	n/a
Forward PE	23.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	562,158
Open	33.93
Previous Close	33.49
Day's Range	33.58 - 34.74
52-Week Range	28.72 - 77.14
Beta	0.88
Analysts	Buy
Price Target	51.75 (+53.24%)
Earnings Date	Nov 2, 2023

About OMCL

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Aug 7, 2001
• Employees: 3,890
• Stock Exchange: NASDAQ
• Ticker Symbol: OMCL

Financial Performance

In 2022, Omnicell's revenue was $1.30 billion, an increase of 14.48% compared to the previous year's $1.13 billion. Earnings were $5.65 million, a decrease of -92.74%.

Analyst Forecast

According to 6 analysts, the average rating for OMCL stock is "Buy." The 12-month stock price forecast is $51.75, which is an increase of 53.24% from the latest price.

Price Target

$51.75

(53.24% upside)

Analyst Consensus: Buy